At the same time, VEGF levels and MVD in tumor-adjacent tissues decreased significantly, suggesting that increased Oatp2 expression improves the treatment effect of sorafenib in a rat model of liver cancer [15]. This evidence concerns the gene SLCO1B1 and neoplasm.